Amelie Harle Discusses Aprepitant for Cough in Lung Cancer

Article

Amelie Harle, MD, PhD, an oncologist at the Christie Hospital in Manchester, United Kingdom, discusses aprepitant (Emend) to reduce cough in patients with lung cancer.

Amelie Harle, MD, PhD, an oncologist at the Christie Hospital in Manchester, United Kingdom, discusses aprepitant (Emend) to reduce cough in patients with lung cancer.

In a recent study, Harle and other researchers explored the NK-1 pathway, which has shown to be relevant to cough in five different species of animals. Centrally acting NK-1 antagonists had not previously been tested as novel antitussive agents in humans.

Cough was measured using recordings as well as questionairres, and findings showed that aprepitant significantly reduced cough in patients with lung cancer.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.